Heshuang Qu

Dr. Heshuang Qu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
HSHenna Salo
Henna Salo
HQHeshuang Qu
Heshuang Qu
DMDimitra Mitsiou
Dimitra Mitsiou
HAHannah Aucott
Hannah Aucott
Jinming HanJinming Han
Jinming Han
HHHelena Erlandsson Harris
Helena Erlandsson Harris
Macrophage plasticity enables cells to obtain different functions over a broad proinflammatory and repairing spectrum. In different conditions, macrophages can be induced by high-mobility group box 1 (HMGB1), a nuclear DNA-binding protein that activates innate immunity, to polarize towards a pro- (M1) or anti-inflammatory (M2) phenotype. In this study, we investigated the phenotypes of murine bone-marrow-derived macrophages (BMDMs) induced by different HMGB1 redox isoforms in depth. Our results demonstrate that disulfide HMGB1 (dsHMGB1) induces a unique macrophage phenotype that secretes pro-inflammatory cytokines, rather than inducing metabolic changes leading to nitric oxide production. Fully reduced HMGB1 (frHMGB1) did not induce macrophage polarization. The migrating function of BMDMs was measured by scratch assay after the stimulation with dsHMGB1 and frHMGB1. Both dsHMGB1 and frHMGB1 induced cell migration. We found that dsHMGB1 mediates cytokine secretion and cellular motility, mainly through toll-like receptor 4 (TLR4). Importantly, our data shows that dsHMGB1 and frHMGB1 induce distinct BMDM polarization phenotypes, and that dsHMGB1 induces a unique phenotype differing from the classical proinflammatory macrophage phenotype.

2 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
HQHeshuang Qu
Heshuang Qu
RHRebecka Heinbäck
Rebecka Heinbäck
HSHenna Salo
Henna Salo
EEEwoud Ewing
Ewoud Ewing
AEAlexander Espinosa
Alexander Espinosa
HHHelena Erlandsson Harris
Helena Erlandsson Harris
Macrophages are key inflammatory immune cells that display dynamic phenotypes and functions in response to their local microenvironment. In different conditions, macrophage polarization can be induced by high-mobility group box 1 (HMGB1), a nuclear DNA-binding protein that activates innate immunity via the Toll-like receptor (TLR) 4, the receptor for advanced glycation end products (RAGE), and C-X-C chemokine receptor (CXCR) 4. This study investigated the phenotypes of murine bone-marrow-derived macrophages (BMDMs) stimulated with different HMGB1 redox isoforms using bulk RNA sequencing (RNA-Seq). Disulfide HMGB1 (dsHMGB1)-stimulated BMDMs showed a similar but distinct transcriptomic profile to LPS/IFNγ- and LPS-stimulated BMDMs. Fully reduced HMGB1 (frHMGB1) did not induce any significant transcriptomic change. Interestingly, compared to LPS/IFNγ- and LPS-, dsHMGB1-stimulated BMDMs showed lipid metabolism and foam cell differentiation gene set enrichment, and oil red O staining revealed that both dsHMGB1 and frHMGB1 alleviated oxidized low-density lipoprotein (oxLDL)-induced foam cells formation. Overall, this work, for the first time, used transcriptomic analysis by RNA-Seq to investigate the impact of HMGB1 stimulation on BMDM polarization. Our results demonstrated that dsHMGB1 and frHMGB1 induced distinct BMDM polarization phenotypes compared to LPS/IFNγ- and LPS- induced phenotypes.

16 June 2026 in EBioMedicine
Verified
Journal Article
Open access
XWXingzhao Wen
Xingzhao Wen
HQHeshuang Qu
Heshuang Qu
MBMalgorzata Benedyk-Machaczka
Malgorzata Benedyk-Machaczka
DCDaphne Chen
Daphne Chen
ESErik Sundberg
Erik Sundberg
HHHelena Erlandsson Harris
Helena Erlandsson Harris
Children with juvenile idiopathic arthritis (JIA) are reported to exhibit increased rates of symptoms affecting emotional regulation and behaviour. However, underlying biological mechanisms remain unclear. Inflammation in the central nervous system (CNS) can be triggered by peripheral immune effects and may contribute to these observations. In this study, we aimed to investigate whether neurobiological alterations are present in systemic JIA (sJIA), whether CNS inflammation occurs during arthritis, and the potential underlying mechanisms. Plasma samples from patients with active sJIA (n = 16) and sex- and age-matched healthy controls (HCs, n = 16), together with paired samples from the same patients with sJIA during inactive disease (n = 12), were analysed using Olink proteomics to determine peripheral neurobiological and inflammation protein profiles. Clinical data was retrieved from the Swedish Paediatric Rheumatology Register and medical charts. CNS neuroinflammatory responses and underlying mechanisms were further investigated using in vivo and in vitro experiments. Patients with active sJIA exhibited altered plasma neurobiological protein profiles compared with HCs. These alterations correlated with higher scores of pain and life impact in patients, suggesting that the altered profiles may reflect neurofunctional changes. Notably, the neurobiological protein profiles remained altered even during inactive phases of the disease. In chronic arthritic mice, microglial activation and impaired neurogenesis were observed in the hippocampus, with no significant cortical changes. RNA-seq analysis implicated mitochondrial dysfunction and oxidative stress in mediating neuroinflammation during chronic arthritis in mice. Haem oxygenase 2 (HMOX2) was identified as a peripheral biomarker indicating microglial activation in the hippocampus (Spearman r = -0.886, P = 0.019). Combined neurobiological and inflammation profiling in patients with sJIA implicated interleukin-6 (IL-6) and interleukin-18 (IL-18) as potential drivers of hippocampal microglial activation during arthritis. Our findings highlight the effects of sJIA and experimental arthritis on the nervous system and provide insights for clinical monitoring and the development of targeted therapeutic strategies. This study was funded by grants from the Swedish Research Council and The Swedish Rheumatism Association.

26 September 2025 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
HQHeshuang Qu
Heshuang Qu
MNManoj Neog
Manoj Neog
KPKarin Palmblad
Karin Palmblad
ESErik Sundberg
Erik Sundberg
ALAlexandra Lövquist
Alexandra Lövquist
HHHelena Erlandsson Harris
Helena Erlandsson Harris
Oligoarticular juvenile idiopathic arthritis (oligoJIA) constitutes nearly 60% of all JIA cases. The immune mechanisms involved in the pathogenesis remain incompletely understood. Few proteomic studies have been performed using synovial fluid (SF) samples. We conducted an exploratory analysis of plasma and SF samples to define inflammatory profiles, assess plasma‐SF correlation and examine longitudinal variations. Using proximity extension assay (PEA), we profiled 92 immune‐related proteins in plasma and Sf from 14 oligoJIA patients (untreated or NSAID‐treated) and plasma from 28 age and sex‐matched healthy controls. Differentially expressed proteins were analysed using gene ontology (GO) and KEGG pathways via STRING. Plasma proteomic immune profiles from oligoJIA patients were highly overlapping with immune profiles of healthy donors. Six proteins were differentially expressed between the two groups. Overall, plasma and SF protein expressions correlated ( r = 0.78), mainly driven by 13 proteins including CCL25, FGF21 and KITLG. However, the differentially expressed proteins in plasma did not correlate with those in SF. Longitudinal analysis of 20 SF and 10 plasma samples from one patient revealed immunosuppressive effects of methotrexate (MTX) with distinct kinetics in plasma and SF. Paired SF samples from five patients revealed that cell chemotaxis was a key feature in early disease, distinguishing it from the persistent phase. Immunoprofiling of SF from patients with oligoJIA identified more disease‐relevant characteristics than analysis of plasma samples. Several proteins, but not all, correlated between plasma and SF. Early‐phase enrichment of chemotaxis suggests that targeting chemokines may offer therapeutic potential for early disease remission.